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ABSTRACT 
Background: Sonography based methods with various tumor markers are currently used to discriminate the type of 
adnexal masses.
Objective: To compare the predictive value of selected sonography-based models along with subjective assessment in 
ovarian cancer prediction.
Material and methods: We analyzed data of 271 women operated because of adnexal masses. All masses were verified 
by histological examination. Preoperative sonography was performed in all patients and various predictive models includ-
ing IOTA group logistic regression model LR1 (LR1), IOTA simple ultrasound-based rules by IOTA (SR), GI-RADS and risk of 
malignancy index (RMI3) were used. ROC curves were constructed and respective AUC’s with 95% CI’s were compared. 
Results: Of 271 masses 78 proved to be malignant including 6 borderline tumors. LR1 had sensitivity of 91.0%, specificity 
of 91.2%, AUC = 0.95 (95% CI: 0.92–0.98). Sensitivity for GI-RADS for 271 patients was 88.5% with specificity of 85% and 
AUC = 0.91 (95% CI: 0.88–0.95). Subjective assessment yielded sensitivity and specificity of 85.9% and 96.9%, respectively 
with AUC = 0.97 (95% CI: 0.94–0.99). SR were applicable in 236 masses and had sensitivity of 90.6% with specificity of 95.3% 
and AUC = 0.93 (95% CI 0.89–0.97). RMI3 was calculated only in 104 women who had CA125 available and had sensitivity 
of 55.3%, specificity of 94% and AUC = 0.85 (95% CI: 0.77–0.93).
Conclusions: Although subjective assessment by the ultrasound expert remains the best current method of adnexal tumors 
preoperative discrimination, the simplicity and high predictive value favor the IOTA SR method, and when not applicable, 
the IOTA LR1 or GI-RADS models to be primarily and effectively used.
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INTRODUCTION
In the past two decades ultrasound examination of the 
female pelvis has gained a vast acceptance by both gy-
naecologists and perinatologists. Currently, it is the most 
common and non-invasive method for the uterus and the 
adnexa imaging and plays a very important role in the ini-
tial pelvic masses evaluation [1]. An accurate prediction of 
an adnexal mass type enables the choice of an appropria-
te surgical method with less aggressive procedures like 
minilaparotomy or laparoscopy indicated in presumably 
benign masses and immediate referral to gynecological 
oncologist in tumors suspected for malignancy [2]. These 
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predictions may save patients life in cases of ovarian cancers 
and save costs if extensive surgery is not needed [3]. If the 
mass seems to be malignant then timed and appropriate 
treatment by gynecologic oncologist is mandatory and is 
related with better long-term prognosis [4–6]. Currently, 
subjective opinion of an ultrasound expert is regarded as 
the most effective method to discriminate adnexal masses 
before surgery [7, 8]. 
The advantage of various mathematical models is 
related to their relative simplicity and a possibility to be 
used by less experienced sonographers who need to triage 
women with adnexal masses [10]. To date, numerous sco-
ring systems for preoperative masses discrimination have 
been developed. Most of these models were developed in 
a relatively small groups of women and later were never 
prospectively validated in the new populations of patients 
with adnexal tumors. The goal of a good prognostic model 
is to minimize false negative results and maximize true 
negative results, and both objectives are difficult to ob-
tain at the same time. For instance, a very popular ROMA 
algorithm used clinically since 2011 does not appear to be 
better than ultrasound examination. In fact, experienced 
gynecologic sonography specialists can distinguish most 
of ovarian tumors before surgery with a significantly higher 
accuracy than ROMA test [10]. 
In 2000 IOTA group has released a consensus state-
ment how to describe and score adnexal masses [11]. The 
first international and multicenter results of validated new 
prognostic models in women with adnexal masses were 
presented more than decade ago by the IOTA (International 
Ovarian Tumor Analysis) Group collaboration [12]. These 
discoveries in adnexal masses sonography had an impact 
on clinical practice but would not be possible before the 
standardization of nomenclature and ultrasound gynecolo-
gical examination. Currently, the most commonly used IOTA 
group models include logistic regression models LR1 and 
LR2 and Simple Rules (SR) [13]. This latter method (SR) has 
been approved and published in 2015 recommendations 
released by the Polish Gynecological Society [14]. IOTA gro-
up models are not the only ones currently used in preope-
rative adnexal masses assessment. Among others, the Risk 
of Malignancy Index (RMI) which incorporates ultrasound 
score, menopausal status and serum CA125 levels was vastly 
used in Great Britain since its release in 1990 with further 
modifications [15–17]. Another, however, less popular ul-
trasound-based scoring system of adnexal masses is called 
Gynecologic-Imaging and Reporting Data System (GI-RADS). 
This method was first introduced by Amor et al. in 2009 [18]. 
These authors attempted to standardize definitions and 
nomenclature for all important ovarian tumor features seen 
during sonographic examination. The GI-RADS method was 
prospectively validated in a multicenter study in 2011 [19]. 
The aim of the current study was to compare the predictive 
value of selected sonography-based models along with 
subjective assessment in the preoperative characterization 
of ovarian masses.
MATERIAL AND METHODS
The study included 271 women with adnexal masses who 
had been preoperatively examined with transvaginal ultraso-
und with the use of a standardized gynecological examination 
method. In Lublin 101 (37.2%) cases were collected and the 
remaining 170 women with adnexal masses were operated 
in Minsk Mazowiecki county hospital. For the purpose of 
this study selected clinical data were recorded and included: 
menopausal status, age, serum CA-125 level, previous ova-
rian cancer history, current hormonal therapy and the pre-
sence of pain during examination. Women after hysterectomy 
who were over 50 years old were considered postmenopausal. 
Exclusion criteria were as follows: pregnancy diagnosed in wo-
man with an adnexal tumor, failure to consent for transvaginal 
ultrasonography, cytology not histology as an outcome and 
surgical procedure that was performed more than 120 days 
of the date of the ultrasound examination. The predetermi-
ned cut-off of 120 days was used in order to ensure that any 
morphological features of a mass scored with preoperative 
sonography would not have had time to change substantially 
prior to surgery as originally set criterion for the IOTA group 
studies [7, 10, 12, 13]. The final outcome was the histological 
diagnosis of surgically removed masses. Histological results 
were classified according to criteria recommended by FIGO 
guidelines. Borderline tumors of the ovary were considered 
malignant for the purpose of this study. Due to retrospective 
nature of this study formal ethical approval was not required. 
Nevertheless, the study protocol was approved by the local 
Bioethical Committee of both centers.
Ultrasound tumor scans were performed with high-end 
ultrasound equipment, GE E8 EXPERT system in Lublin and 
GE S8 system in Minsk Mazowiecki. Transvaginal probes of 
these systems used ultrasound beam frequencies between 
5.0 and 9.0 MHz and abdominal probes used frequencies 
between 3.5 and 5.0 MHz. Adnexal masses were examined 
with transvaginal gray-scale followed by color and “power” 
Doppler ultrasound examination using a standardized tech-
nique. Pulse repetition frequency (PRF) in “power” Doppler 
mode was set to 0.3 kHz or 0.6 kHz. During the examination 
of tumor vascularity, color gain was gradually increased 
until flash artifact appeared, then it was decreased to a level 
where slow flow in blood vessels was still visible. If the tumor 
was too large to be assessed with transvaginal probe, the 
transabdominal probes were also used. 
All scans in Minsk Mazowiecki hospital were performed 
by a single gynecologist (JK) who was trained in IOTA terms 
and sonographic tumor criteria. This examiner at the time 
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table blood flow (color score = 1), minimal blood flow (color 
score = 2), moderate blood flow (color score = 3) or abundant 
blood flow (color score = 4). The specific diagnosis of tumor 
histological type as suggested by the original ultrasound 
examiner in the first sonography report was also recorded.
IOTA Simple Rules method
Simple ultrasound based rules were assessed accor-
ding to the original IOTA protocol published in 2008 [14].
The selected criteria used in this method are presented in 
Table 1. According to the original IOTA method, an adnexal 
mass was classified as malignant if at least one M-feature 
and no B-features were present and vice versa. When no B 
or M-features were present or if both B and M-features were 
present, then SR were considered inconclusive (uncertain), 
the mass was unclassifiable with this method and another 
second stage diagnostic method was required for these 
residual tumors.
RMI — Risk of Malignancy Index assessment
The third modification of RMI, also called “RMI3” was 
used in our analysis. According to the modified original RMI 
method [16] this score was calculated as below:
 
RMI3 score = U x M x CA125; 
 
where “U” are ultrasound features suggestive of mali-
gnancy: the presence of a multilocular cystic lesion; solid 
areas; bilateral lesions; ascites; intra-abdominal metasta-
ses. Zero or one point is given for each feature. If a total 
score is 0 or 1 point, it yields U = 1, a score of 2 points or 
more yields U = 3. In premenopausal women M = 1 and in 
postmenopausal patients M = 3. CA-125 level is used directly 
in this equation with the units/mL measured in blood serum. 
For the purpose of this study we used the “RMI3” shortcut in 
tables and figure’s descriptions. The cut-off for malignancy 
is set at RMI3 = 200 [16].
IOTA logistic regression LR1 model 
The IOTA LR1was used as originally described by Tim-
merman et al. [12]. This logistic regression model consists of 
of the study performed about 500 gynecological scans per 
year which is in concordance with level II examinator accor-
ding to the Education and Practical Standards Committee 
and the European Federation of Societies for Ultrasound in 
Medicine and Biology (EFSUMB) guidelines [20]. In Lublin 
all scans were assessed by the level III examiner (AC) who 
is also an IOTA expert and one of principal investigators of 
IOTA studies.
Tumor sonographic morphology assessment
For the purpose of this analysis, in each women the 
mass with the most complex ultrasound morphology was 
used in case of bilateral adnexal masses. If both masses had 
similar sonographic features the largest tumor or the one 
most easily accessible with ultrasound was included. The 
masses were described using the terms and definitions 
published by the IOTA group [13]. Papillary projections were 
defined as projections of solid tissue into the cystic cavity 
arising from the cyst wall or from a septum with a height 
greater than or equal to 3 mm. We have measured the largest 
solid component other than a papillary projection. These 
included solid components that apparently were not pro-
truding into the cystic mass cavity. In accordance with the 
IOTA consensus statement if a papillary projection was the 
largest solid component of a mass, the papillary projection 
was recorded and measured both as a papillary projection 
and as the largest solid component [13].
The presence of ascites and fluid in the pouch of Douglas 
was noted. Intraabdominal metastases were scored to be 
present if any extrauterine mass inconsistent with normal 
physiology was found in the pelvis and/or abdomen. In 
particular these masses had to be visible as small tumors on 
peritoneal surfaces when ascites was present or as separate, 
vascularized solid masses without ascites seen on transab-
dominal or transvaginal imaging.
Subjective assessment
All tumors were assessed using pattern recognition [7] 
with the aim to identify typical sonographic adnexal tumors 
patterns. The vascularization of the tumors on color Doppler 
was described using the IOTA color score method: no detec-
Table 1. IOTA Simple Rules assessment 
Rules for predicting malignant tumor (M-rules) Rules for predicting benign tumor (B-rules)
M1 Irregular solid tumor B1 Unilocular cyst
M2 Presence of ascites B2 Presence of solid components where the largest solid component has a largest diameter < 7 mm
M3 At least four papillary structures B3 Presence of acoustic shadows
M4 Irregular multilocular-solid tumor with the largest 
diameter > 100 mm B4 Smooth multilocular tumor with the largest diameter < 100 mm
M5 Very strong blood flow (color score 4) B5 No blood flow (color score 1)
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12 variables: (1) age of the patient (in years); (2) the presence 
of ascites (yes = 1, no = 0); (3) the presence of blood flow 
within a papillary projection (yes = 1, no = 0); (4) largest 
diameter of the solid component (expressed in mm but 
with no increase above 50 mm); (5) irregular internal cyst 
walls (yes = 1, no= 0); (6) the presence of acoustic sha-
dows (yes = 1, no = 0); (7) personal history of ovarian cancer 
(yes = 1, no = 0); (8) current hormonal therapy (yes = 1, 
no = 0); (9) largest diameter of the lesion (mm); (10) the 
presence of pain during the examination (yes = 1, no = 0); 
(11) the presence of a purely solid tumor (yes= 1, no = 0); 
and (12) the color score (1, 2, 3 or 4). 
The LR1 model’s estimated probability of malignancy for 
an adnexal tumor equals 1/(1 + e−z), where z = − 6.7468 + 
0.0326 (1) + 1.5513 (2) + 1.1737 (3) + 0.0496 (4) + 1.1421 (5) 
− 2.3550 (6) + 1.5985 (7) − 0.9983 (8) + 0.00841 (9) − 
0.8577 (10) + 0.9281 (11) + 0.4916 (12), and “e” is the math-
ematical constant and the base value of natural logarithms. 
The cut-off risk for malignant masses was established as 
originally published at 0.1 which equals to 10% risk of ma-
lignancy [12].
GI-RADS model 
All masses were scored according to the GI-RADS pro-
gnostic model that was first published by Amor et al. [18] The 
GI-RADS classification system is explained in Table 2. A tumor 
was regarded as probably malignant if it was graded 4 or 
5 points.
Results were presented as absolute frequency (percen-
tage) for nominal variables and as median (range) for con-
tinuous variables. For subjective assessment (SA), as well as 
for RMI3, GI-RADS, IOTA LR1 and IOTA SR Areas under the 
Receiver Operating Characteristic (ROC) curves (AUCs) with 
95% confidence intervals (CI) were calculated to compare 
the discriminatory performance of the studied models. In 
addition, sensitivity and specificity as well as the positive 
and negative likelihood ratios (LR+ and LR-) were calculated 
for the cutoff points proposed in the original articles. For 
different methods efficacy comparison receiver operating 
characteristic (ROC) curves were constructed and corre-
sponding AUCs were calculated. The ROC curve displays 
the relationship between the test true positive ratio and 
the false positive ratio for a range of cutoff values. The AUC 
comparison was used to test various diagnostic methods 
ability to discriminate benign and malignant masses.
All statistical analyses were performed with the use of 
Stata Statistical Software, Release 11 (Stata Corp. College 
Station, TX, USA). 
RESULTS
Of 271 masses 78 proved to be malignant including 
6 borderline tumors. Table 3 presents sensitivities and 
specificities with related LR+ and LR- values for all used 
predictive methods and calculated AUC’s with standard 
errors and 95% confidence intervals for all used prognostic 
methods. Preoperative serum CA-125 concentrations were 
available in 104 women and therefore RMI3 values could 
be calculated only for this group of patients. Figure 1 shows 
AUC’s calculated for ROC curves for all studied methods. The 
highest predictive values were found for subjective expert 
assessment and for IOTA group logistic regression mo-
del 1. The LR1 model had sensitivity of 91,0%, specificity 
of 91.2% and AUC = 0.95 (95% CI: 0.92–0.98). Subjective 
assessment yielded sensitivity and specificity of 85.9% and 
96.9%, respectively with AUC = 0.97 (95% CI: 0.94–0.99). For 
GI-RADS model sensitivity was 8.5% with specificity of 85% 
and AUC = 0.91 (95% CI: 0.88–0.95). Simple rules method 
was applicable in 236 masses (87%) and had sensitivity of 
90.6% with specificity of 95.3% and AUC = 0.93 (95% CI 
0.89–0.97). RMI3 had sensitivity of 55.3% with specificity of 
94% and AUC = 0.85 (95% CI: 0.77–0.93). Predictive values 
of the studied prognostic tests for an expert (level III) and 
non-expert (level II) examiners are presented in Table 4. In 
a subgroup of premenopausal patients level II examiner 
Table 2. Criteria used for GI-RADS adnexal tumors classification [18]
GI-RADS grade Diagnosis Est. prob. malignancy Detail
1 Definitive benign 0% Normal ovaries identified and no adnexal mass seen
2 Very probably benign < 1% Adnexal lesions thought to be of functional origin, e.g. follicles, corpora lutea, hemorrhagic cysts
3 Probably benign 1–4%
Neoplastic adnexal lesions thought to be benign, such as endometrioma, 
teratoma, simple cyst, hydrosalpinx, paraovarian cyst, peritoneal pseudocyst, 
pedunculated myoma, or findings suggestive of pelvic inflammatory disease
4 Probably malignant 5–20% Any adnexal lesion not included in GI-RADS 1–3 and with one or two findings suggestive of malignancy*
5 Very probably malignant > 20% Adnexal masses with three or more findings suggestive of malignancy*
*Thick papillary projections, thick septations, solid areas and/or ascites, defined according to IOTA criteria, and vascularization within solid areas, papillary projections or 
central area of a solid tumor on color or power Doppler assessment. “Est. prob.” — estimated probability
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Figure 1. Comparison of receiver characteristic curves AUC’s for SA, 
IOTA LR1, IOTA SR and GI-RADS predictive methods. LR1 — logistic 
regression model 1; GI-RADS — Gynecologic Data and Reporting 
System; SR — Simple Rules have three levels (benign, inconclusive 
and malignant) and is represented by a ROC curve with two points
Table 3. Predictive methods AUCs with 95% CIs in the differentiation between benign and malignant adnexal tumors and sensitivity, specificity 
with positive and negative likelihood ratios calculation in 271 women with adnexal tumors 
Method Patients AUC* Std. Err. AUC’s 95% CI Sens. Spec. LR+ LR–
Subjective assessment 271 0.96 0.01 0.94 0.98 85.90% 96.90% 27.63 0.14
IOTA LR1 271 0.95 0.013 0.92 0.97 91.00% 91.20% 10.34 0.09
GI-RADS 271 0.91 0.018 0.87 0.95 88.40% 84.90% 5.88 0.13
Simple Rules 236 0.92 0.02 0.89 0.96 90.60% 95.30% 19.48 0.09
RMI3 104 0.84 0.039 0.77 0.92 55.20% 93.90% 9.11 0.47
*AUC — area under receiver-operator characteristics curve 
Abbreviations: LR1 — Logistic Regression model 1; GI-RADS — Gynecologic Imaging Data and Reporting System; SR — Simple Rules have three levels (benign, 
inconclusive and malignant) and is represented by the ROC curve with two points; RMI3 — Risk of Malignancy Index 3; Sens. — sensitivity, Spec. — specificity;  
LR+ — positive likelihood ratio; LR– — negative likelihood ratio
prediction with subjective assessment yielded sensitivity 
59.1% and specificity of 98%, which was much lower than for 
any of the ultrasound based models. The data indicate that 
subjective assessment predictive value was almost matched 
by the LR1 model while GI-RADS with SR methods had also 
very high predictive values in the studied group of women 
with adnexal masses. 
The use of GI-RADS method produced relatively high 
number of false positive results with 29 tumors classified by 
level II examiner as malignant when final histology proved 
to be benign. False positive results were mostly found in 
premenopausal women. The reason of such results were 
probably related to the difficulties in classification of tumors 
with the GI-RADS score equal to 4. Similar problems and 
results were obtained by Amor et al. who have reported 
nearly 80% of false positive results if the tumors were scored 
4 points [18, 19]. The lowest predictive performance was 
related to RMI3 model, where 17 from 38 cancers (44.7%) 
were incorrectly classified as being benign. 
Table 4. Sensitivity and specificity of various prognostic methods as assessed by level II and level III examiners
Examiner — level III Sens. Spec. ACC PPV NPV
Subjective assessment 96.40% 93.30% 95.00% 94.74% 95.45%
IOTA LR1 94.60% 82.20% 89.10% 86.90% 92.50%
GI-RADS 94.60% 75.50% 86.10% 82.80% 91.90%
Simple Rules 94.10% 94.10% 94.10% 96.00% 91.40%
RMI3 62.50% 86.60% 71.70% 88.20% 59.10%
Examiner — level II Sens. Spec. ACC PPV NPV
Subjective assessment 59.10% 97.90% 92.90% 81.20% 94.10%
IOTA LR1 81.80% 93.90% 92.30% 66.60% 97.20%
GI-RADS 72.70% 87.80% 85.80% 47.00% 95.60%
Simple Rules 76.90% 95.60% 94.00% 62.50% 97.70%
RMI3 42.80% 96.10% 84.60% 75.00% 85.90%
Abbreviations: LR1 — logistic regression model 1; GI-RADS — Gynecologic Imaging Data and Reporting System; SR — Simple Rules have three levels (benign, 
inconclusive and malignant) and is represented by the ROC curve with two points; RMI3 — Risk of Malignancy Index 3; Sens. — sensitivity, Spec. — specificity;  
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DISCUSSION
Accurate prognosis of the type of adnexal mass detected 
during ultrasound evaluation remains the most important 
issue in ovarian tumors classification. Prognostic ultraso-
und models should precisely indicate tumor type because 
incorrect classification may lead to an underestimation of 
the risk of ovarian mass malignancy. Delayed referral of 
a woman with suspected adnexal tumor to gynecologic on-
cology specialist is related to several factors, and the lack of 
widely-accepted and effective preoperative risk assessment 
strategies remains one of the most important issues [21]. 
In cases of false positive results unnecessary surgery is also 
highly probable. Unfortunately, experienced sonographic 
examiners are not always available and to mimic their ca-
pabilities and skills multiple ultrasound-based prognostic 
models have been constructed in order to help non-expert 
operators to more efficiently discriminate between benign 
and malignant ovarian tumors.
Our results indicate that IOTA Risk LR1 and GI-RADS 
models as well as the IOTA SR method can appropriately 
predict the presence of ovarian malignancy in a vast majority 
of adnexal masses in women who are candidates for surgical 
procedures. We have also confirmed that an expert could 
correctly classify most of the malignant ovarian tumors. Less 
experienced examiners should use prognostic models, pre-
ferably suggested by the IOTA group as these methods 
are relatively easy to learn and they retain high predictive 
values even in hands of level II ultrasound operators [22, 
23]. In our group of patients SR method could be applied 
to classify 87% (236/271) of tumors. This was a higher rate 
than originally reported 75% of the adnexal masses which 
could be classified with this method [13], probably due to 
a relatively high percentage of malignant cases. Subjective 
assessment by level II examiner in our study was good for 
the correct preoperative classification of simple cysts, most 
endometriomas and mature teratomas, as well as for the 
majority of fibromas, tubo-ovarian abscesses and advanced 
FIGO stage ovarian cancers. 
We have demonstrated that the IOTA group LR1 pro-
gnostic model and GI-RADS performed well when used 
both by an experienced and less experienced operators 
of ultrasound systems. Our study is another example of 
the external validation of the prognostic ultrasound-based 
models currently used in clinical practice. The results indi-
cate that even without a special expertise less experienced 
sonographers are also able to correctly classify the vast 
majority of adnexal masses if they use well-established cri-
teria of benign and malignant tumors. The strengths of this 
study are related to its multicenter design with a relatively 
large groups of patients diagnosed and operated in both 
oncologic and non-oncologic hospitals and to the use of 
multiple predictive models as well as the same, standardized 
IOTA group terminology of adnexal masses by both expert 
and non-expert ultrasound examiners. Our study has also 
limitations which include its retrospective design and sub-
optimal predictive models efficacy comparisons related to 
the lack of CA125 data for all operated women. Because of 
this missing information we were unable to calculate the 
RMI3 values in a substantial proportion of studied patients.
To the best of our knowledge, this is the first study in 
Poland that attempted to externally validate the IOTA group 
LR1 model and compared the results with subjective tumor 
assessment and other commonly used prognostic models 
that included RMI, SR and GI-RADS. Two groups of patients 
were examined preoperatively in different centers with a mi-
xed populations of both low and high ovarian malignancies 
prevalence. Examiners had two levels of experience and tra-
ining in ultrasound characteristics of adnexal masses. Sono-
grapher’s medium or low experience in adnexal pathology 
differentiation is probably the most commonly encountered 
situation in our country, where majority of primary ultrasound 
scans are performed in an outpatient setting by radiologists 
or gynecologists without specialized oncological training 
i.e. level I or level II [24]. Although rare, some of the complex 
adnexal masses are difficult to classify even by the experts in 
gynecological and oncological ultrasound who could not pre-
dict the correct diagnosis in approximately 8% of tumors [25]. 
It is important to note that as many as 60% of these masses 
turned out to be malignant following their surgical removal. 
This observation suggests to classify all difficult tumors as 
probably malignant when an expert opinion is not readily 
available [26]. Another option is to use newer IOTA models 
such as LR2 model which incorporates only 6 variables witho-
ut CA-125 assessment [27] or the ADNEX model which uses 
3 clinical and 6 ultrasound variables with CA-125 necessary 
to predict stage II–IV ovarian cancers [28]. For both methods 
basic IOTA training is essential as cutoff point for predicting 
malignancy has extremely strong influence on sensitivity and 
specificity of the tested diagnostic model. 
In conclusion, this retrospective study has shown that 
all ultrasound-based prognostic methods performed well 
in the preoperative discrimination of adnexal masses. In the 
absence of an expert examiner’s opinion the IOTA group 
models such as Simple Rules and LR1 could be preferably 
used by the less experienced sonographers.
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